Key result
This letter critiques a prior study on low molecular weight heparins for VTE prophylaxis, highlighting methodological biases such as mismatched data sources and flawed risk stratification.
Answers are grounded in this paper and cite their sources.
This letter highlights significant methodological biases in a study evaluating LMWH prophylaxis in internal medicine patients, questioning its conclusions on underutilization.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Ortega et al. (2005) conducted a letter in Venous thromboembolism. Low molecular weight heparins (LMWH) vs. No LMWH (including unfractionated heparin and oral anticoagulants) was evaluated. This letter critiques a prior study on low molecular weight heparins for VTE prophylaxis, highlighting methodological biases such as mismatched data sources and flawed risk stratification.
Synapse has enriched 10 related papers. Consider them for comparative context: